# C4 Therapeutics, Inc.: Form 8-K, filed Jan 9, 2024

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2024-01-09
- Accepted by EDGAR: Jan 9, 2024, 16:06 ET
- Period: 2024-01-09
- Accession: 0001628280-24-000947
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828024000947/cccc-20240109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828024000947/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828024000947/cccc-20240109.htm

Filed Jan 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-000947. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.